David Simon is the managing member, the CEO, and Co-Chief Investment Officer of Twin Capital Management, LLC. Outside of his professional life, David Simon of Twin Capital supports Solving Kids’ Cancer (SKC), which supports and provides information to families of children with neuroblastoma.
In a bid to help children with neuroblastoma access life-saving trials faster, SKC recently appointed Dr. Emmanouela Gbandi as trials coordinator for neuroblastoma. It is the first appointment specifically dedicated to a single childhood cancer.
More clinical trials are needed for children with neuroblastoma. This will help in the development of life-saving therapies and an increased understanding of the disease. However, because neuroblastoma is rare, research programs conducted around the world are done in isolation.
Dr. Gbandi’s role will involve bringing together researchers, hospitals, and pharmaceutical companies, harmonizing efforts toward finding effective treatments for curing or reducing the symptoms of neuroblastoma. She will develop specialist knowledge of the disease, identify synergies between trials, and highlight problems quickly. By fostering integrative work and collaboration, better trials can be designed, increasing their likelihood of success.
